The Burlington, N.C., provider of clinical laboratory services said that excluding $7.7 million in restructuring charges and other charges related to the retirement of the company's chief executive, the company earned $108.4 million, or 85 cents a share, compared with $93.1 million, or 67 cents a share, a year earlier.